SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J958. A total of 4 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $537,416 | -39.6% | 24,800 | -42.6% | 0.00% | – |
| Q3 2023 | $889,056 | -71.5% | 43,200 | -34.9% | 0.00% | -100.0% |
| Q2 2023 | $3,122,128 | +45.9% | 66,400 | +18.4% | 0.00% | 0.0% |
| Q4 2022 | $2,139,654 | +35.2% | 56,100 | +38.9% | 0.00% | 0.0% |
| Q3 2022 | $1,582,000 | -8.4% | 40,400 | -24.5% | 0.00% | 0.0% |
| Q2 2022 | $1,728,000 | – | 53,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 32,000 | $3,065,000 | 0.03% |
| IMC-Chicago, LLC | 14,000 | $1,341,000 | 0.00% |
| SIMPLEX TRADING, LLC | 111 | $1,063,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 1,100 | $105,000 | 0.00% |